assumption people drug 10 days results announced gilead trial today suggest 5 day course treatment work effectively double number people treated says porges long term clinicians likely want bevy anti viral drugs different ways disabling virus arsenal says timothy sheahan virologist university north carolina chapel hill teamed gilead researchers study remdesivir potential antiviral resistance says hedge potential good line second- third- fourth- fifth line antiviral researchers furiously testing wide range therapies early results not definitive not encouraging malaria drugs chloroquine hydroxychloroquine anti inflammatory effects drew attention physicians public countries studies humans failed consistent benefit highlighted risks posed effects drugs heart